Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Milena Cappello"'
Autor:
Massimiliano Scalvenzi, Milena Cappello, Claudia Costa, Gabriella Fabbrocini, Mariaantonietta Luciano, Alessia Villani
Publikováno v:
Dermatology and Therapy, Vol 10, Iss 3, Pp 465-468 (2020)
Abstract Introduction Locally advanced basal cell carcinoma (laBCC) has always represented an uncommon, difficult-to-treat form of skin cancer, but approval of the Hedgehog inhibitor (HHI) vismodegib has provided an effective, well-tolerated therapy.
Externí odkaz:
https://doaj.org/article/542d78d5d87342d795aa857cd9117763
Autor:
Alessia Villani, Matteo Megna, Gabriella Fabbrocini, Milena Cappello, Maria Antonietta Luciano, Claudia Costa, Massimiliano Scalvenzi
Publikováno v:
Dermatology and Therapy, Vol 9, Iss 4, Pp 719-724 (2019)
Abstract Introduction Although non-melanoma skin cancers (NMSCs) are associated with a very low mortality risk, they have been reported to have a major impact on patients’ health-related quality of life (HRQoL). Vismodegib is a therapy for patients
Externí odkaz:
https://doaj.org/article/e989de3bf0724a6bafbeff640e751ff0
Autor:
Alessia Villani, Gabriella Fabbrocini, Milena Cappello, Claudia Costa, Massimiliano Scalvenzi
Publikováno v:
Dermatology and Therapy, Vol 9, Iss 3, Pp 505-510 (2019)
Abstract Introduction Non-melanoma skin cancer (NMSC) is the most common type of human tumor, with an estimated five million new cases each year. NMSC has been described as having a major impact on the health-related quality of life of the patient. V
Externí odkaz:
https://doaj.org/article/a6ce9b22fec84d09af4f0de86e5aac67
Autor:
Mariaantonietta Luciano, Claudia Costa, Milena Cappello, Massimiliano Scalvenzi, Gabriella Fabbrocini, Alessia Villani
Publikováno v:
Dermatology and Therapy, Vol 10, Iss 3, Pp 465-468 (2020)
Dermatology and Therapy
Dermatology and Therapy
Introduction Locally advanced basal cell carcinoma (laBCC) has always represented an uncommon, difficult-to-treat form of skin cancer, but approval of the Hedgehog inhibitor (HHI) vismodegib has provided an effective, well-tolerated therapy. While th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddb5fce755fef1d1be2bffe18595fc4f
https://doaj.org/article/542d78d5d87342d795aa857cd9117763
https://doaj.org/article/542d78d5d87342d795aa857cd9117763
Autor:
Massimiliano Scalvenzi, Gabriella Fabbrocini, Claudia Costa, Milena Cappello, Alessia Villani
Publikováno v:
Clinical and Experimental Dermatology. 45:1044-1046
Locally advanced basal cell carcinoma (laBCC) has always represented an uncommon, difficult to treat form of skin cancer until the hedgehog inhibitor (HHI) vismodegib was approved. Approximately 80% of laBCCs occur in the head and neck region causing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea4645094bc4aabd33b8fc4c0a0677f4
https://doi.org/10.1111/ced.14287
https://doi.org/10.1111/ced.14287
Autor:
Mariateresa Cantelli, Milena Cappello, Maria Vastarella, Angela Patrì, Massimiliano Scalvenzi, Gabriella Fabbrocini
Publikováno v:
Skin Appendage Disord
Introduction: Vismodegib is the first-in-class inhibitor of the sonic hedgehog pathway useful in the treatment of locally advanced or metastatic basal cell carcinoma (BCC) that is not amenable to surgery and radiation therapy. Common adverse events o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99d2b885d9e6108b455d595c09da1e22
https://europepmc.org/articles/PMC7706510/
https://europepmc.org/articles/PMC7706510/
Autor:
Milena Cappello, Alessia Villani, Claudia Costa, Massimo Mascolo, Gabriella Fabbrocini, Massimiliano Scalvenzi, Gaia De Fata Salvatores, Francesca Pagliuca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4e51423ca0c40635e25cc8dc360002
http://hdl.handle.net/11588/722328
http://hdl.handle.net/11588/722328
Autor:
Claudia Costa, Massimiliano Scalvenzi, Vincenzo Greco, Matteo Megna, Gabriella Fabbrocini, Vincenzo Marino, Milena Cappello, Alessia Villani
Background Intradermal naevi represent a benign histopathological variant of common melanocytic naevi. Studies describing dermoscopic criteria of dermal naevi are very limited. Objectives To identify dermoscopic features of dermal naevi in order to f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89688752cb97a09fa3fac3939724761e
http://hdl.handle.net/11588/814758
http://hdl.handle.net/11588/814758
Autor:
Gabriella Fabbrocini, Claudia Costa, Milena Cappello, Alessia Villani, Massimiliano Scalvenzi
Publikováno v:
Journal of Dermatological Treatment. 33:602-603
Dear Editor,Basal cell carcinoma (BCC) is the most common periocular malignant tumour (1). Surgical excision represents the gold-standard treatment with low risk of recurrences. However, a small su...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::180f2636c16e97f1e36161e071409bbb
https://doi.org/10.1080/09546634.2020.1771262
https://doi.org/10.1080/09546634.2020.1771262